Corrigendum: Role of ARRB1 in prognosis and immunotherapy: a pan-cancer analysis
Yingquan Ye, Haili Jiang, Yue Wu, Gaoxiang Wang, Yi Huang, Weijie Sun, Mei Zhang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —National Natural Science Foundation of China 10.13039/501100001809
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Bladder and Urothelial Cancer Treatments
In the published article, there was an error in the Funding statement. The funding number was incorrect. The correct Funding statement appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.